Function of circulating TNF in rheumatoid arthritis patients with infliximab: Link to clinical response.

被引：0
作者：
Marotte, H
Miossec, P
机构：
[1] Hop Edouard Herriot, INSERM, U 403, Lyon, France
[2] Hop Edouard Herriot, Dept Immunol, Lyon, France
[3] Hop Edouard Herriot, Dept Rheumatol, Lyon, France
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
[41]   METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB [J].
Denarie, D. ;
Rinaudo, M. ;
Thomas, T. ;
Paul, S. ;
Marotte, H. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 :459-459
[42]   Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns [J].
Flendrie, M. ;
Creemers, M. C. W. ;
van Riel, P. L. C. M. .
RHEUMATOLOGY, 2007, 46 (01) :146-149
[43]   Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response [J].
Haraoui, B ;
Cameron, L ;
Ouellet, M ;
White, B .
JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) :31-36
[44]   MHC association with response to infliximab therapy in rheumatoid arthritis patients. [J].
Fernandez-Gutierrez, B ;
Martinez, A ;
Salido, M ;
Bonilla, G ;
Pascual-Salcedo, D ;
de la Concha, EG .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :S128-S128
[45]   Predictors of response to etanercept and infliximab among patients with rheumatoid arthritis (RA) [J].
Hyrich, KL ;
Watson, KD ;
Symmons, DPM ;
Silman, AJ .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :429-429
[46]   PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION [J].
Eng, G. ;
Fana, V. ;
Omerovic, E. ;
Hojsgaard, P. ;
Lindegaard, H. M. ;
Jensen, E. K. ;
Bouchelouche, P. N. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 :230-230
[47]   Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis [J].
Laas, Karin ;
Peltomaa, Ritva ;
Kautiainen, Hannu ;
Leirisalo-Repo, Marjatta .
CLINICAL RHEUMATOLOGY, 2008, 27 (07) :927-932
[48]   Infliximab in rheumatoid arthritis - Can the response be predicted? [J].
Hrycaj, P ;
Korczowska, I ;
Lacki, JK .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 :403-403
[49]   Early and late effect of infliximab on immunophenotype of circulating dendritic cells in rheumatoid arthritis patients [J].
Balanescu, A ;
Radu, E ;
Nat, R ;
Regalia, T ;
Bojinca, V ;
Ionescu, R ;
Constantinescu, C ;
Berghea, F ;
Sava, C ;
Predeteanu, D .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :295-296
[50]   Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis [J].
Karin Laas ;
Ritva Peltomaa ;
Hannu Kautiainen ;
Marjatta Leirisalo-Repo .
Clinical Rheumatology, 2008, 27 :927-932
12345